Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view.
暂无分享,去创建一个
[1] R. Wallace,,et al. Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] Young Kil Park,et al. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. , 2009, American journal of respiratory and critical care medicine.
[3] K. Fukunaga,et al. Therapeutic effects of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease. , 2009, Chest.
[4] S. Dhillon,et al. Lady Windermere syndrome: middle lobe bronchiectasis and Mycobacterium avium complex infection due to voluntary cough suppression. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] R. Wallace,,et al. Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria , 2012, Clinical Microbiology Reviews.
[6] Robert Horsburgh,et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. , 2007, American journal of respiratory and critical care medicine.
[7] William A. Black,et al. Assessment of Partial Sequencing of the 65-Kilodalton Heat Shock Protein Gene (hsp65) for Routine Identification of Mycobacterium Species Isolated from Clinical Sources , 2004, Journal of Clinical Microbiology.
[8] B. Dautzenberg,et al. Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium. ANRS Trial 033 Curavium Group. Agence Nationale de Recherche sur le Sida. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] J. Gaillard,et al. Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm(41) and rrl Sequencing , 2010, Antimicrobial Agents and Chemotherapy.
[10] Chang Ki Kim,et al. Treatment of Refractory Mycobacterium avium Complex Lung Disease with a Moxifloxacin-Containing Regimen , 2013, Antimicrobial Agents and Chemotherapy.
[11] I. Laurenson,et al. Systematic review of tattoo-associated skin infection with rapidly growing mycobacteria and public health investigation of a cluster in Scotland, 2010. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[12] E. Tortoli. Microbiological Features and Clinical Relevance of New Species of the Genus Mycobacterium , 2014, Clinical Microbiology Reviews.
[13] J. Falkinham,et al. Epidemiology of infection by nontuberculous mycobacteria , 1996, Clinical microbiology reviews.
[14] S. Shafran. Prevention and treatment of disseminated Mycobacterium avium complex infection in human immunodeficiency virus-infected individuals. , 1998, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[15] Z. Samra,et al. Management of Nontuberculous Mycobacteria-Induced Cervical Lymphadenitis With Observation Alone , 2008, The Pediatric infectious disease journal.
[16] R. Wallace,,et al. Results of operation in Mycobacterium avium-intracellulare lung disease. , 1998, The Annals of thoracic surgery.
[17] D. Curran‐Everett,et al. Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] M. Doyle,et al. Matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry (MS) for the identification of mycobacteria from MBBacT ALERT 3D liquid cultures and Lowenstein–Jensen (LJ) solid cultures , 2014, Journal of Clinical Pathology.
[19] A. Hill,et al. Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] E. Cambau,et al. Infections à mycobactéries atypiques liées à des soins esthétiques en France, 2001–2010 , 2011 .
[21] Yuansha Chen,et al. Web-Accessible Database of hsp65 Sequences from Mycobacterium Reference Strains , 2011, Journal of Clinical Microbiology.
[22] L. Strasfeld,et al. Disseminated Mycobacterium genavense with pulmonary nodules in a kidney transplant recipient: case report and review of the literature , 2011, Transplant infectious disease : an official journal of the Transplantation Society.
[23] E. Böttger,et al. Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus. , 2014, The Journal of antimicrobial chemotherapy.
[24] T. Shim,et al. Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs. , 2011, Respiratory medicine.
[25] D. Rimland,et al. Randomized, Open-Label Trial of Azithromycin Plus Ethambutol vs. Clarithromycin Plus Ethambutol as Therapy for Mycobacterium avium Complex Bacteremia in Patients with Human Immunodeficiency Virus Infection , 1998 .
[26] J. Prins,et al. Surgical excision versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children: a multicenter, randomized, controlled trial. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] E. Kuijper,et al. Clinical Manifestations, Diagnosis, and Treatment of Mycobacterium haemophilum Infections , 2011, Clinical Microbiology Reviews.
[28] J. Singer,et al. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. , 1996, The New England journal of medicine.
[29] F. Alcaide,et al. Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease , 2009, European Respiratory Journal.
[30] C. Kemper,et al. Mycobacterium Avium Complex , 2017 .
[31] V. Waters,et al. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. , 2016, The Cochrane database of systematic reviews.
[32] F. Sarfo,et al. Clinical Efficacy of Combination of Rifampin and Streptomycin for Treatment of Mycobacterium ulcerans Disease , 2010, Antimicrobial Agents and Chemotherapy.
[33] J. Warren,et al. Catheter-related bloodstream infections caused by rapidly growing nontuberculous mycobacteria: a case series including rare species. , 2008, Diagnostic microbiology and infectious disease.
[34] P. Roslev,et al. Mycobacterium avium Complex in Day Care Hot Water Systems, and Persistence of Live Cells and DNA in Hot Water Pipes , 2013, Current Microbiology.
[35] E. Tortoli. Clinical manifestations of nontuberculous mycobacteria infections. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[36] A. Niimi,et al. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[37] R. Wallace,,et al. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus , 1996, Antimicrobial agents and chemotherapy.
[38] D. Griffith. Emergence of nontuberculous mycobacteria as pathogens in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.
[39] J. Reveille,et al. Human immunodeficiency virus-associated atypical mycobacterial skeletal infections. , 1996, Seminars in arthritis and rheumatism.
[40] J. Lindeboom. Surgical treatment for nontuberculous mycobacterial (NTM) cervicofacial lymphadenitis in children. , 2012, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[41] R. Wallace,,et al. Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population. , 1996, The Journal of infectious diseases.
[42] M. Drancourt,et al. rpoB-Based Identification of Nonpigmented and Late-Pigmenting Rapidly Growing Mycobacteria , 2003, Journal of Clinical Microbiology.
[43] Young Kil Park,et al. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. , 2011, American journal of respiratory and critical care medicine.
[44] R. Wallace,,et al. Rifampin-resistant Mycobacterium kansasii. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[45] S. Giglio,et al. Mycobacterium avium complex – the role of potable water in disease transmission , 2012, Journal of applied microbiology.
[46] L. Moulin,et al. First evidence of amoebae-mycobacteria association in drinking water network. , 2014, Environmental science & technology.
[47] M. Bourgeois,et al. Mycobactéries atypiques et mucoviscidose , 2004 .
[48] Yansheng Zhang,et al. An outbreak of Mycobacterium chelonae infection following liposuction. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[49] W. Webb,et al. Detailed analysis of the radiographic presentation of Mycobacterium kansasii lung disease in patients with HIV infection. , 2008, Chest.
[50] R. Wallace,,et al. Initial (6-month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex lung disease in human immunodeficiency virus-negative patients. , 1998, The Journal of infectious diseases.
[51] E. Böttger,et al. Two-laboratory collaborative study on identification of mycobacteria: molecular versus phenotypic methods , 1996, Journal of clinical microbiology.
[52] M. Clement,et al. PREVENTION AND TREATMENT , 1944 .
[53] K. Winthrop,et al. Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy , 2013, Nature Reviews Rheumatology.
[54] R. Wallace,,et al. A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae , 2008, Antimicrobial Agents and Chemotherapy.
[55] W. Ludwig,et al. Differentiation of Phylogenetically Related Slowly Growing Mycobacteria Based on 16S-23S rRNA Gene Internal Transcribed Spacer Sequences , 1998, Journal of Clinical Microbiology.
[56] A. Bracker,et al. An outbreak of hypersensitivity pneumonitis at a metalworking plant: a longitudinal assessment of intervention effectiveness. , 2003, Applied occupational and environmental hygiene.
[57] C. Piersimoni,et al. Pulmonary infections associated with non-tuberculous mycobacteria in immunocompetent patients. , 2008, The Lancet. Infectious diseases.
[58] I. Raad,et al. Rapidly growing mycobacterial bloodstream infections. , 2013, The Lancet. Infectious diseases.
[59] C. Horsburgh,et al. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[60] J. Parkhill,et al. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study , 2013, The Lancet.
[61] S. Escolano,et al. Antibiotic Susceptibility Pattern ofMycobacterium marinum , 2000, Antimicrobial Agents and Chemotherapy.
[62] P. Berche,et al. Value of the Chlorhexidine Decontamination Method for Recovery of Nontuberculous Mycobacteria from Sputum Samples of Patients with Cystic Fibrosis , 2006, Journal of Clinical Microbiology.
[63] T. Byrd,et al. Differential Antibiotic Susceptibility of Mycobacterium abscessus Variants in Biofilms and Macrophages Compared to That of Planktonic Bacteria , 2008, Antimicrobial Agents and Chemotherapy.
[64] R. Wallace,,et al. In Vitro Activity of Amikacin against Isolates of Mycobacterium avium Complex with Proposed MIC Breakpoints and Finding of a 16S rRNA Gene Mutation in Treated Isolates , 2014, Journal of Clinical Microbiology.
[65] J. Raleigh,et al. Treatment of pulmonary disease due to Mycobacterium kansasii: recent experience with rifampin. , 1981, Reviews of infectious diseases.
[66] M. Kramer,et al. Differentiation of Mycobacterium kansasii infection from Mycobacterium tuberculosis infection: comparison of clinical features, radiological appearance, and outcome , 2007, European Journal of Clinical Microbiology & Infectious Diseases.
[67] J. Desenclos,et al. Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreak , 2001, The Lancet.
[68] E. Cambau,et al. Classification Algorithm for Subspecies Identification within the Mycobacterium abscessus Species, Based on Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry , 2014, Journal of Clinical Microbiology.
[69] William Girard,et al. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. , 2006, American journal of respiratory and critical care medicine.
[70] E. Tortoli. Impact of Genotypic Studies on Mycobacterial Taxonomy: the New Mycobacteria of the 1990s , 2003, Clinical Microbiology Reviews.
[71] F. Mello,et al. Phenotypic and molecular characterization of quinolone resistance in Mycobacterium abscessus subsp. bolletii recovered from postsurgical infections. , 2012, Journal of medical microbiology.
[72] O. Chosidow,et al. Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates. , 2002, Archives of internal medicine.
[73] E. H. Runyon,et al. Distinguishing mycobacteria by the niacin test; a modified procedure. , 1959, American review of tuberculosis.
[74] M. Yakrus,et al. Nontuberculous mycobacterial disease following hot tub exposure. , 2001, Emerging infectious diseases.
[75] J. Theis,et al. Mycobacterium xenopi infection of the spine: a case report and literature review. , 2000, Spine.
[76] D. van Soolingen,et al. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria. , 2012, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[77] E. Y. Kim,et al. Treatment Outcome of Combination Therapy Including Clarithromycin for Mycobacterium avium Complex Pulmonary Disease , 2011, The Korean journal of internal medicine.
[78] H. Hallander,et al. Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination coverage. , 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[79] Kenjiro Furuta,et al. [Cervical lymphadenitis caused by Mycobacterium avium in an immunocompetent adult]. , 2012, Kekkaku : [Tuberculosis].
[80] F. Sung,et al. Rheumatoid Arthritis Increases the Risk of Nontuberculosis Mycobacterial Disease and Active Pulmonary Tuberculosis , 2014, PloS one.
[81] B. Petrini,et al. Infection with Mycobacterium malmoense in Sweden: report of 221 cases. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[82] B. Gicquel,et al. Mycobacterium abscessus: a new antibiotic nightmare. , 2012, The Journal of antimicrobial chemotherapy.
[83] K. K. Lai,et al. Mycobacterial Cervical Lymphadenopathy: Relation of Etiologic Agents to Age , 1984 .
[84] B. Dautzenberg,et al. Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS. Clarithromycin Study Group of France. , 1995, Chest.
[85] P. Jenkins,et al. Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment. , 2003, Respiratory medicine.
[86] A. Dujon,et al. Pulmonary resection for Mycobacterium xenopi pulmonary infection. , 2001, Annals of Thoracic Surgery.
[87] John D. Mitchell,et al. Anatomic lung resection for nontuberculous mycobacterial disease. , 2008, The Annals of thoracic surgery.
[88] K. Skolnik,et al. Nontuberculous Mycobacteria in Cystic Fibrosis , 2016, Current Treatment Options in Infectious Diseases.
[89] R. Wallace,,et al. Clinical Trial of Clarithromycin for Cutaneous (Disseminated) Infection due to Mycobacterium chelonae , 1993, Annals of Internal Medicine.
[90] Mikio Oka,et al. A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease. , 2007, Respiratory medicine.
[91] C. Ki,et al. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. , 2015, American journal of respiratory and critical care medicine.
[92] G. Bretzel,et al. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial , 2010, The Lancet.
[93] P. de Rijk,et al. First Cultivation and Characterization of Mycobacterium ulcerans from the Environment , 2008, PLoS neglected tropical diseases.
[94] F. Portaels,et al. Mycobacterium ulcerans infection: control, diagnosis, and treatment. , 2006, The Lancet. Infectious diseases.
[95] J. Chun,et al. The Genome Sequence of ‘Mycobacterium massiliense’ Strain CIP 108297 Suggests the Independent Taxonomic Status of the Mycobacterium abscessus Complex at the Subspecies Level , 2013, PloS one.
[96] R. Wallace,,et al. In Vitro Activity of Amikacin against Isolates of Mycobacterium avium Complex with Proposed MIC Breakpoints and Finding of a 16S rRNA Gene Mutation in Treated Isolates , 2013, Journal of Clinical Microbiology.
[97] J. Philley,et al. Nontuberculous mycobacterial (NTM) lung disease: the top ten essentials. , 2014, Respiratory medicine.
[98] Ying Zhang,et al. Reduced Pyrazinamidase Activity and the Natural Resistance of Mycobacterium kansasii to the Antituberculosis Drug Pyrazinamide , 1999, Antimicrobial Agents and Chemotherapy.
[99] T. Hanaoka,et al. Surgery for Mycobacterium avium complex lung disease in the clarithromycin era. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[100] T. Iwamoto,et al. [Detection of rpoB mutations in rifampicin-resistant Mycobacterium kansasii]. , 2006, Kekkaku : [Tuberculosis].
[101] P. Nahid,et al. Update in tuberculosis and nontuberculous mycobacterial disease 2012. , 2013, American journal of respiratory and critical care medicine.
[102] E. Wolinsky. Nontuberculous mycobacteria and associated diseases. , 2015, The American review of respiratory disease.
[103] C. Daley,et al. The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment. , 2012, American journal of respiratory and critical care medicine.
[104] E. Wolinsky. Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[105] Eric Caumes,et al. Outbreak of Nontuberculous Mycobacterial Subcutaneous Infections Related to Multiple Mesotherapy Injections , 2009, Journal of Clinical Microbiology.
[106] W. Ricketts,et al. Human-to-human transmission of Mycobacterium kansasii or victims of a shared source? , 2014, European Respiratory Journal.
[107] C. Piersimoni,et al. Extrapulmonary Infections Associated with Nontuberculous Mycobacteria in Immunocompetent Persons , 2009, Emerging infectious diseases.
[108] B. Guglielmo,et al. The new macrolides. Azithromycin and clarithromycin. , 1994, The Western journal of medicine.
[109] J. Yim,et al. The drug susceptibility profile and inducible resistance to macrolides of Mycobacterium abscessus and Mycobacterium massiliense in Korea. , 2015, Diagnostic microbiology and infectious disease.
[110] G. French,et al. Rifampin Resistance in Mycobacterium kansasii Is Associated with rpoB Mutations , 2001, Antimicrobial Agents and Chemotherapy.
[111] J. Garcia,et al. Nontuberculous Mycobacterial Disease Mortality in the United States, 1999–2010: A Population-Based Comparative Study , 2014, PloS one.
[112] U. Flúckiger,et al. Vertebral osteomyelitis caused by non-tuberculous mycobacteria. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[113] Tanya S. Glaser,et al. Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease. , 2014, Annals of the American Thoracic Society.
[114] V. Jarlier,et al. Characterization of mutations in Mycobacterium smegmatis involved in resistance to fluoroquinolones , 1994, Antimicrobial Agents and Chemotherapy.
[115] R. Wallace,,et al. Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease. , 2014, Chest.
[116] J. Meningaud,et al. Clinical management of rapidly growing mycobacterial cutaneous infections in patients after mesotherapy. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[117] B. Dautzenberg,et al. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. , 1991, The American review of respiratory disease.
[118] Paige L. Williams,et al. A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[119] B. Gicquel,et al. Genetic analysis of new 16S rRNA mutations conferring aminoglycoside resistance in Mycobacterium abscessus. , 2011, The Journal of antimicrobial chemotherapy.
[120] R. Wallace,,et al. Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. , 2005, The Journal of antimicrobial chemotherapy.
[121] X. Nassif,et al. Clonal Relationship and Differentiation among Mycobacterium abscessus Isolates as Determined Using the Semiautomated Repetitive Extragenic Palindromic Sequence PCR-Based DiversiLab System , 2014, Journal of Clinical Microbiology.
[122] Yazdan,et al. Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France , 2008, Thorax.
[123] R. Wallace,,et al. A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae. , 1998, The Journal of infectious diseases.
[124] C. Garzelli,et al. Genetic diversity and phylogeny of Mycobacterium avium. , 2014, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[125] M. Egger,et al. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. , 2007, The Lancet. Infectious diseases.
[126] H. Edelstein,et al. Mycobacterium marinum skin infections. Report of 31 cases and review of the literature. , 1994, Archives of internal medicine.
[127] A. Montiel,et al. Occurrence of Mycobacteria in Water Treatment Lines and in Water Distribution Systems , 2002, Applied and Environmental Microbiology.
[128] Pneumonia caused by Mycobacterium kansasii in a series of patients without recognised immune defect. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.